Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.

Edit Content

    Healthcare, Education

    Monophasic Synovial Sarcoma of the Posterior Pharyngeal Wall: A Rare Case Study

    January 26, 2026 ayushis Comments Off on Monophasic Synovial Sarcoma of the Posterior Pharyngeal Wall: A Rare Case Study
    Three people in medical attire are standing and talking in a brightly lit hallway. The image is blurred, and there is an exclamation mark inside a triangle warning icon overlayed in the center.
    Content Warning:
    This article references a published medical case study that includes graphic surgical images involving the head and neck region. While the information may be valuable and informative, some readers may find the images difficult to view. Please proceed with care.

    Synovial sarcoma most often develops in the extremities, but in rare cases, it can arise in the head and neck region. A published case study in the European Archives of Oto-Rhino-Laryngology highlights one such rare presentation: monophasic synovial sarcoma originating in the posterior pharyngeal wall.

    Although uncommon, head and neck synovial sarcoma presents unique diagnostic and treatment challenges due to the complexity of surrounding anatomy and the critical functions involved in breathing, swallowing, and speech. Studies like this one provide valuable insight for clinicians and patients navigating these rare diagnoses.

    A rare and challenging diagnosis

    In this case, a 25-year-old patient presented with symptoms including difficulty breathing while lying down, snoring, and trouble swallowing solid foods. Initial imaging and biopsy suggested a benign tumor, a situation that is not uncommon with synovial sarcoma due to its tendency to appear well-defined and non-aggressive on early scans.

    As symptoms progressed, further imaging and pathology revealed the diagnosis of monophasic synovial sarcoma of the posterior pharyngeal wall. This highlights a known challenge with synovial sarcoma: it can closely mimic benign conditions, leading to delays in diagnosis, particularly in rare anatomical locations like the head and neck.

    Imaging and pathology findings

    Advanced imaging showed a heterogeneous mass with areas of calcification—an imaging feature seen in a subset of synovial sarcoma cases. Definitive diagnosis was confirmed through histopathology, immunohistochemistry, and cytogenetic testing, which identified the characteristic t(X;18) chromosomal translocation associated with synovial sarcoma.

    The tumor was classified as monophasic, meaning it consisted primarily of spindle-shaped cells, a subtype that is frequently misdiagnosed due to its resemblance to other soft tissue tumors.

    Surgical treatment and reconstruction

    The primary treatment approach was wide surgical excision aimed at achieving clear margins. Due to the tumor’s size and location, the surgery required complex access and reconstruction. The surgical team used a lateral trapezius flap—a less commonly used reconstructive technique—to repair the defect created after tumor removal.

    This reconstructive approach allowed restoration of the pharyngeal wall while preserving critical structures involved in swallowing and airway protection. The study highlights this technique as a potential option for large defects in similar cases.

    Role of additional therapies

    Following surgery, the patient received radiation therapy. Chemotherapy was initiated but discontinued after one cycle due to side effects. At follow-up, the patient showed no evidence of disease and was able to resume oral intake with supportive therapy.

    While the role of chemotherapy in head and neck synovial sarcoma remains debated, studies suggest that a multidisciplinary approach—including surgery, radiation, and careful long-term surveillance—offers the best chance for disease control.

    Why this study matters

    Although this case represents a single patient, it adds to a limited body of knowledge about synovial sarcoma in the head and neck region. For patients and families affected by synovial sarcoma outside of the extremities, studies like this help improve understanding of how the disease can present, how it is diagnosed, and what treatment options may look like.

    Importantly, it also reinforces the value of second opinions, specialized pathology review, and care at centers experienced with sarcoma—especially when symptoms persist despite reassurance that a mass may be benign.

    Looking ahead

    Head and neck synovial sarcoma remains rare, but continued documentation and study are essential to improving diagnosis, treatment strategies, and long-term outcomes. Research like this contributes to ongoing efforts to refine surgical techniques, explore reconstruction options, and better understand the biology of this complex disease.

    For patients navigating synovial sarcoma of the head and neck, awareness and advocacy remain critical tools—both for timely diagnosis and access to specialized care.

    Content Warning:
    This article references a published medical case study that includes graphic surgical images involving the head and neck region. While the information may be valuable and informative, some readers may find the images difficult to view. Please proceed with care. Original study here.

    For more detailed information about Synovial Sarcoma resources and support, please visit our website.

    ayushis

    Post navigation

    Previous
    Next

    Search

    Categories

    • Black Flag Racing (2)
    • Children (1)
    • CHOP (3)
    • Development (4)
    • Dr. Theodore Laetsch (3)
    • Education (6)
    • Healthcare (5)
    • Latest News (7)
    • Rare Cancer (1)
    • Research (15)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (3)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • A wooden judge’s gavel with a gold band rests on top of a British flag, symbolizing law or justice in the United Kingdom.
      A Turning Point for Rare Cancers
    • A scientist wearing safety glasses and gloves closely examines samples through a microscope in a laboratory setting, concentrating on her research.
      Afamitresgene Autoleucel (Afami-cel): T-Cell Therapy Shows Promise in Synovial Sarcoma
    • A virtual meeting with five professionals, three men and two women, each in their own space, looking at their cameras. Names and titles are displayed for some participants at the bottom of their video frames.
      Synovial Sarcoma Foundation Hosts Second Community Webinar Highlighting Research Momentum

    Tags

    Afami-cel Black Flag Racing Brigham and Women’s Hospital Callan Spence cancer-testis antigen Cancer Research Chase Spence Chas Spence CHOP Clinical Trials Dr. Rachel Hurly Dr. Ted Laetsch fibroblast fibroblast epigenome ground breaking human cell therapy immune-cell therapy Infant JAMA Internal Medicine Julie Kramer MAGE-A4 Market Growth Monophasic Synovial Sarcoma National Tumor Board Nature Communications P300 Parotid Gland Patient Stories Pediatric Oncology Penn Medicine Prasterone Rare Cancer research Sarcoma Synovial Sarcoma Synovial Sarcoma Foundation synovial sarcoma survivor synovial sarcoma treatment T-Cell Therapy TCR-NK TECELRA UK’s Rare Cancers Bill webinar Zelluna ZI-MA4-1

    Related posts

    A wooden judge’s gavel with a gold band rests on top of a British flag, symbolizing law or justice in the United Kingdom.
    Latest News, Rare Cancer

    A Turning Point for Rare Cancers

    March 11, 2026 ayushis Comments Off on A Turning Point for Rare Cancers

    What the UK’s Rare Cancers Bill Means for the Synovial Sarcoma Community For decades, patients diagnosed with rare cancers have faced a structural disadvantage. Fewer treatment options. Fewer clinical trials. Less research funding. Now a new law in the United Kingdom aims to change that. The Rare Cancers Bill, introduced by Dr Scott Arthur MP, […]

    A scientist wearing safety glasses and gloves closely examines samples through a microscope in a laboratory setting, concentrating on her research.
    Healthcare, Research

    Afamitresgene Autoleucel (Afami-cel): T-Cell Therapy Shows Promise in Synovial Sarcoma

    March 3, 2026 ayushis Comments Off on Afamitresgene Autoleucel (Afami-cel): T-Cell Therapy Shows Promise in Synovial Sarcoma

    Synovial sarcoma is a rare and often aggressive cancer that can become difficult to treat once it spreads. Traditional chemotherapy options are limited, and outcomes for metastatic disease remain poor. New research is exploring whether advanced T-cell therapies may offer another option. A recent clinical trial evaluated afamitresgene autoleucel (afami-cel), an engineered T-cell therapy designed […]

    A virtual meeting with five professionals, three men and two women, each in their own space, looking at their cameras. Names and titles are displayed for some participants at the bottom of their video frames.
    Latest News, Education

    Synovial Sarcoma Foundation Hosts Second Community Webinar Highlighting Research Momentum

    February 23, 2026 ayushis Comments Off on Synovial Sarcoma Foundation Hosts Second Community Webinar Highlighting Research Momentum

    On February 19, 2026, the Synovial Sarcoma Foundation brought together patients, families, clinicians, and researchers from around the world for its second community webinar—an evening focused on progress, partnership, and hope. The full webinar recording is available to watch below: The webinar was moderated by Nathan Imperiale, Chairman of the Board, and featured: Highlights Foundation […]

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch